Ekso Bionics 

$1.04
34
+$0.01+0.97% 今天

統計

當日最高
1.05
當日最低
1.01
52週最高
3.13
52週最低
0.75
成交量
13,434
平均成交量
86,393
市值
22.13M
市盈率
-
股息收益率
-
股息
-

即將到來

收益

31Oct預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
-0.33
-0.26
-0.18
-0.1
預期每股收益
-0.105
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 EKSO 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

6.25$平均價格目標
最高估價為 $10。
來自過去 6 個月內的 2 個評級。這不是投資建議。
買入
100%
持有
0%
賣出
0%

關於

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.
Show more...
首席執行官
Jack Peurach
員工
70
國家
US
ISIN
US2826443010

上市公司